• Home
  • Biomarkers predictive of response to pembrolizumab in head and neck cancer.

Biomarkers predictive of response to pembrolizumab in head and neck cancer.

Author List
Pfister DG, Haddad RI, Worden FP, Weiss J, Mehra R, Chow LQM, Liu SV, Kang H, Saba NF, Wirth LJ, Sukari A, Massarelli E, Ayers M, Albright A, Webber AL, Mogg R, Lunceford J, Huang L, Cristescu R, Cheng J, Seiwert TY, Bauml JM
Publication
Cancer medicine
Publication ID (Profile URL)
https://researcherprofiles.org/profile/422327624
Publication Year
2022
PubMed ID
36479637
Publication Title
Pfister DG, Haddad RI, Worden FP, Weiss J, Mehra R, Chow LQM, Liu SV, Kang H, Saba NF, Wirth LJ, Sukari A, Massarelli E, Ayers M, Albright A, Webber AL, Mogg R, Lunceford J, Huang L, Cristescu R, Cheng J, Seiwert TY, Bauml JM. Biomarkers predictive of response to pembrolizumab in head and neck cancer. Cancer Med. 2023 03; 12(6):6603-6614.